GlassScriptPhysician profile
Andrea D Murphy
NPI 1467709097
$9,673.52
in general payments reported to CMS, 2019-2025
18 companies · $3,195 in 2025
The $3,195 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $725 · 2022: $695 · 2023: $2,643 · 2024: $2,416 · 2025: $3,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,405 · Food and Beverage: $3,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,405.00 |
| Food and Beverage | $3,848.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $2,684.38 | 2023-2025 | Vyepti |
| Abbvie INC. | $2,372.98 | 2021-2025 | |
| Astellas Pharma US INC | $1,995.00 | 2023 | |
| Pfizer INC. | $773.40 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $308.90 | 2021-2025 | Ajovy |
| Lilly USA, LLC | $305.59 | 2021-2024 | Emgality |
| Amgen INC. | $218.12 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $205.69 | 2022 | |
| Tonix Medicines, INC. | $180.36 | 2024-2025 | Zembrace Symtouch |
| Axsome Therapeutics, INC. | $168.36 | 2025 | Symbravo |
| Impel Pharmaceuticals INC. | $109.03 | 2023 | Trudhesa |
| Biohaven Pharmaceuticals, INC. | $100.64 | 2021 | |
| Scilex Pharmaceuticals INC. | $94.47 | 2023-2024 | Ztlido |
| Collegium Pharmaceutical, INC. | $63.27 | 2025 | Belbuca |
| Azurity Pharmaceuticals, INC. | $37.25 | 2025 | Horizant |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $21.97 | 2024 | Somatuline Depot, Onivyde |
| Currax Pharmaceuticals LLC | $17.21 | 2023 | Onzetra Xsail |
| Upsher-Smith Laboratories LLC | $16.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.